These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5947508)

  • 1. Cytostatic treatment of polycythaemia vera with a methylbenzylhydrazine derivative.
    Martin H; Schubert JC
    Ger Med Mon; 1966 Aug; 11(8):315-6. PubMed ID: 5947508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytostatic treatment of polycythemia vera with a methylbenzylhydrazine derivative].
    Martin H; Schubert JC
    Dtsch Med Wochenschr; 1966 Jan; 91(2):55-7. PubMed ID: 5900941
    [No Abstract]   [Full Text] [Related]  

  • 3. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 4. New cytostatic drugs in the management of polycythaemia vera.
    Nagy G; Balázs C; Petrányi G
    Ther Hung; 1972; 20(1):10-3. PubMed ID: 5057661
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of polycythaemia vera with Myelobromol.
    Nagy G; Petrányi G; Arany L; Rácz M
    Ther Hung; 1969; 17(3):123-6. PubMed ID: 5351155
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic use of Zitostop in polycythaemia vera.
    Nagy G; Balázs C; Petrányi G
    Ther Hung; 1971; 19(1):16-8. PubMed ID: 5093539
    [No Abstract]   [Full Text] [Related]  

  • 7. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytostatic treatment of polycythaemia rubra vera. Comparison of the effects of some cytostatics in 100 patients in a period of five years.
    Nagy G; Léhi M
    Haematologia (Budap); 1975; 9(3-4):283-6. PubMed ID: 181298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of polycythemia vera with hydroxyurea.
    Tatarsky I; Sharon R
    Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Black discoloration of nails in polycythaemia vera].
    Konrad H; Wollina U
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):723-5. PubMed ID: 16173981
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon alfa: effects of long-term treatment for polycythemia vera.
    Silver RT
    Semin Hematol; 1997 Jan; 34(1):40-50. PubMed ID: 9025161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pipobroman in the treatment of some cases of polycythemia vera].
    Bignotti G; Visca U; Confalonieri C
    Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of cytostatic therapy of polycythemia vera].
    Kovaleva LG; Kho PI
    Gematol Transfuziol; 1986 Jul; 31(7):42-6. PubMed ID: 3744014
    [No Abstract]   [Full Text] [Related]  

  • 14. New cytostatic drugs in the management of polycythaemia vera.
    Nagy G; Balázs C; Petrányi G
    Acta Med Acad Sci Hung; 1971; 28(3):211-6. PubMed ID: 5153639
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.
    Bodrogi I; Bálint I
    Ther Hung; 1979; 27(2):77-83. PubMed ID: 494144
    [No Abstract]   [Full Text] [Related]  

  • 16. A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
    Barosi G; Birgegard G; Finazzi G; Griesshammer M; Harrison C; Hasselbalch H; Kiladijan JJ; Lengfelder E; Mesa R; Mc Mullin MF; Passamonti F; Reilly JT; Vannucchi AM; Barbui T
    Br J Haematol; 2010 Mar; 148(6):961-3. PubMed ID: 19930182
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.
    Harrison CN; Griesshammer M; Miller C; Masszi T; Passamonti F; Zachee P; Durrant S; Pane F; Guglielmelli P; Verstovsek S; Jones MM; Hunter DS; Sun W; Li J; Khan M; Habr D; Kiladjian JJ
    Br J Haematol; 2018 Jul; 182(2):279-284. PubMed ID: 29984424
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of polycythaemia vera with myelobromol.
    Szentkláray J; Hartmann E
    Ther Hung; 1966; 14(4):143-8. PubMed ID: 5963796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of Imiphos in diseases of the blood system].
    Pinus AG
    Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):26-31. PubMed ID: 5260223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.